At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Texas based CEO’ operating in the Medical space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Co-founder & CEO of CareStack
Abhi is a visionary entrepreneur who brings a decade of expertise building technology platforms in US healthcare. His business acumen, decision making, and analytical skills are shaping CareStack to be a force in the dental and retail healthcare space.
Follow Abilash Krishna:
About CareStack: CareStack is a practice management platform for dental groups to manage all of their software and daily operations through one platform.
William F McKeon
CEO of Texas Medical Center
Mr. William F. McKeon serves as the Chief Executive Officer of Texas Medical Center in Houston, TX. Prior to joining the TMC leadership, he was the CEO of Cellnovo Limited. Mr. McKeon served as President of MicroPort Medical (Shanghai) Co. Ltd. since August 2006. He joined MicroPort Medical Co. Ltd. in 1997, where he was responsible for its marketing, eCommerce and eHealth initiatives. His professional career began at Du Pont where he held several marketing and business development roles in the United States and Europe. Prior to joining MicroPort Medical Co.
Follow William F McKeon:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Robert C Robbins
President and CEO of Texas Medical Center
Robert C. Robbins became President and Chief Executive Officer of Texas Medical Center on November 5, 2012. Prior to that, he was professor and chairman of the Department of Cardiothoracic Surgery at Stanford University School of Medicine, where he served as a member of the faculty since 1993. He served as director of the Stanford Cardiovascular Institute, of the Heart- Lung and Lung Transplantation Programs, and of the Cardiothoracic Transplantation Laboratory. Dr. Robbins is an internationally recognized cardiac surgeon who has focused his clinical efforts on acquired cardiac diseases with a special expertise in the surgical treatment of congestive heart failure. His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels, and automated vascular anastomotic devices. He served as the guest editor of the Circulation Surgical Supplement from 2002 to 2005, president of the International Society of Heart and Lung Transplantation in 2006, president of the Bay Area Society of Thoracic Surgeons in 2006, chair of the American Heart Association Cardiovascular Surgery and Anesthesia Council from 2007 to 2009, councilor-at-large for the Western Thoracic Surgical Association from 2007 to 2009, and on the President’s Cabinet at California Polytechnic State University from 2006 to 2012. In California, he served on the Board of Directors for two publically traded companies, Cohesion Technologies from 2000 to 2003 and Cardica, Inc. from 2000 to2009, and as a director for several other privately held Bay Area biotechnology companies. In 2009, he was elected to the American Heart Association Western States Affiliate Board of Directors and currently serves as president of the organization. He was elected to the Board of Trustees of Millsaps College in Mississippi in 2010. Dr. Robbins has lectured widely and published more than 292 peer reviewed articles. He earned his bachelor’s degree in chemistry from Millsaps College in 1979 and a medical degree from the University of Mississippi in 1983. He completed his general surgical training at the University of Mississippi in 1989 and his cardiothoracic training at Stanford University in 1992. Dr. Robbins completed post-doctoral research at Columbia University and the National Institutes of Health, and congenital heart surgical fellowships at Emory University and Royal Children’s Hospital. An ex-officio of the Houston Livestock Show & Rodeo, Dr. Robbins currently sits on the Advisory Board of the Ronald McDonald House in Houston and on the Board of Directors for Texas Medical Center, the Greater Houston Partnership, the Greater Houston Convention and Visitors Bureau, the Houston Academy of Medicine Texas Medical Center Library, the Houston Technology Center, and the Friends of Houston Academy of Medicine Texas Medical Center Library.
Follow Robert C Robbins:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
President, CEO of CHRISTUS Health
Ernie Sadau is responsible for day-to-day operations of CHRISTUS Health and lends extensive expertise in developing programs to improve quality and clinical integration and preparing the organization to capitalize on the opportunities of the future. Ernie joined CHRISTUS as Senior Vice President of Patient and Resident Care Operations in 2006. His title was changed to Senior Vice President and Chief Operating Officer in 2008 as he expanded his role and oversight within the organization. Ernie also served as the Chief Diversity and Inclusion Officer for CHRISTUS Health, developing the strategic initiatives and processes to ensure that CHRISTUS is living out its commitment to valuing differences and strengthening the ministry’s culture of inclusion. Before joining CHRISTUS, Ernie served in many roles at Adventist Health System from 1983-2006, holding various executive positions in the organization’s many hospitals and systems, including Chief Financial Officer, Administrator, and President and CEO of Adventist Health System/Midwest in Hinsdale, Ill., which includes five hospitals, over 60 physician practices, surgery and imaging centers and several home care agencies. During his tenure with Adventist, Ernie led successful hospital acquisitions and joint ventures; implemented thriving physician recruiting, community relations and employee development programs and developed many necessary medical services in the communities he served, including opening the only freestanding Emergency Room in Illinois and a Level III Neonatal Intensive Care Unit. Ernie holds a master’s degree in Hospital Administration from Southwest Texas State University in San Marcos, Texas. He received his undergraduate degree in Business Administration from the University of North Texas. Ernie is a Fellow of the American College of Health Care Executives, and was named an Up & Comer by Modern Healthcare magazine in 2000, an award that honors rising young stars in the health care management field.
Follow Ernie Sadau:
About CHRISTUS Health: Christus Health is an international Catholic, faith-based, not-for-profit health system
CEO of Texas Medical Technology
Follow Omri Shafran:
About SureSpot, Texas Medical Technology: Texas Medical Technology specializes in the sale and distribution of wide range of medical equipment.
Founder & CEO of Medici
Clinton Phillips is the founder of Medici and launched the company in early 2017 with a vision to create technology that would revolutionize the way doctors provide care to their patients. As a serial-entrepreneur Clinton previously founded 2nd.MD in response to frustrations he had experienced when seeking medical care for his daughter, Gabi, who had suffered a stroke shortly after birth. 2nd.MD has since helped thousands of people in over 45 countries gain access to high-quality second opinions with outcomes that has saved lives and lowered healthcare and recovery costs for patients, providers and carriers. Before this, Clinton served as a consultant to The Vitality Group working to lower healthcare spending through employee education and engagement programs. Clinton is also a certified Chiropractor and founded the successful Colorado-based Aspen Back & Body, a non-surgical rehabilitation clinic for people with back problems. Originally from South Africa, Clinton and his family now reside in Austin, Texas.
Follow Clinton Phillips:
About 2nd.MD, Medici: Medici is a mobile technology platform that provides text, video, and voice chats between patients and doctors.
Founder & CEO of Wheel
Follow Michelle Davey:
About Wheel: Wheel is a healthcare technology company that brings together the tech infrastructure and clinicians to power virtual care and telehealth.
Founder, Managing Member & CEO of Cell Point
Since its beginning, Greg Colip is a founding member of Cell>Point and has provided financial support to the company. Mr. Colip brings over 38 years of experience in healthcare marketing and legal. Prior to establishing the company with Jerry Bryant and Terry Colip, Mr. Colip was a corporate mergers and acquisition lawyer and served as Deputy General Counsel for Panhandle Eastern Corporation (which has since been split up with part of the company’s subsidiaries owned by Duke Energy and the remaining part-owned by CMS Energy), provided legal counsel and development work for various independent power projects, served as Vice President and General Counsel for the Gulfco Division of Chromalloy American Corporation and was a production/marketing manager for The Upjohn Company (now part of Pharmacia). At Panhandle Eastern, Mr. Colip was involved in numerous complex venture, merger, spin-off, and acquisition transactions, including the $2.4 billion acquisition of Texas Eastern Corporation and the $1.2 billion drop down and spin-off of Anadarko Petroleum Corporation. At Upjohn, Mr. Colip was the production/marketing systems manager for the corticosteroid and anticoagulant product lines. Mr. Colip received his bachelor’s degree in production management and industrial engineering in 1970, followed by his M.B.A. two years later and a J.D. in 1978. His higher education was at Indiana University, and Greg is proud to call it his Alma Mater.
Follow Greg Colip:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Julia Taylor Cheek
CEO and Founder of EverlyWell
Julia Taylor Cheek is the CEO and Founder of EverlyWell, a digital health startup empowering consumers to order, self-collect, and understand lab tests. Based in Austin, EverlyWell launched in June 2016 after raising $3M in capital and garnering awards from Tech Crunch and Rock Health. They now have over 5,000 customers in 46 states. Julia was also named the number one female entrepreneur to watch by CIO magazine for 2017. Prior to founding EverlyWell in 2015, Julia was the Vice President of Corporate Development and Strategy at MoneyGram International, a public financial services company that operates in 200 countries. As the youngest VP in the company, she worked for MoneyGram’s CFO for several years, leading corporate transactions, restructuring projects, and special projects for the CEO. Before that, she served as the founding Director of Strategy and Operations at the George W. Bush Institute and played a key role in building the organization from just a handful of employees to the Presidential Center that you see today at Southern Methodist University. After attending Vanderbilt, Julia started her career in management consulting at Deloitte and went on to earn her MBA from the Harvard Business School, where she graduated as a Baker Scholar with high distinction. She also is a former multiple World Champion equestrian, officially retiring in 2009.
Follow Julia Taylor Cheek:
About EverlyWell: EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.
CEO of Aurinia Pharmaceuticals
Richard Glickman has served as Chairman of ESSA’s board of directors since October 2010, and is responsible for the management of the board of directors to ensure ESSA has appropriate objectives, an effective strategy and is operating in accordance with a high standard of corporate governance. Richard was a co-founder, Chairman and Chief Executive Officer of Aspreva Pharmaceuticals Inc. Prior to establishing Aspreva, Richard was the co-founder and Chief Executive Officer of StressGen Biotechnologies Corporation. Richard currently serves on the board of directors of Cardiome, Vida Pharmaceuticals and Engene Inc., and is Chairman of the board of directors of Aurinia Pharmaceuticals Inc. In addition, Richard has served on many other biotechnology boards of directors. Richard received the 2004 Ernst & Young Entrepreneur of the Year Award for the Pacific Region Life Sciences Group, both Canada’s and British Columbia’s Top 40 under 40 Award for Entrepreneurs, the 2006 BC Biotech Leadership Award and the Lupus Foundation of America Leadership Award.
Follow Richard Glickman:
About Aurinia Pharmaceuticals, Aurinia Pharmaceuticals, enGene, Lumira Ventures: Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
CEO, Co-Founder of NurseDash
Follow Jake Kohl:
About NurseDash: NurseDash is the on-demand healthcare marketplace for providers that need staffing support and qualified candidates looking for open shifts.
CEO, Co-Founder of NurseDash
Follow Andy Chen:
About NurseDash: NurseDash is the on-demand healthcare marketplace for providers that need staffing support and qualified candidates looking for open shifts.
CEO of Vivature
Mouzon Bass is the CEO of Vivature.
Follow Mouzon Bass:
About Vivature: Vivature provides practice management software for campus health centers and athletic departments to streamline billing and track injuries.
Founder and CEO of Hera Health Solutions
Follow Idicula Mathew:
About Hera Health Solutions: Hera Health Solutions is a pharmaceutical company specializing in the development and commercialization of long term treatments.
Co-Founder, Chairman & CEO of First Stop Health
Patrick Spain started First Stop Health because of his own unsatisfactory experience with the healthcare system and his desire to improve that experience for others. Spain is a serial entrepreneur who has founded or cofounded four Web-based companies. Co-founder and long-time chairman and CEO of Hoover’s, Inc., Spain led the company from a small book publisher in 1992 to a profitable, publicly traded online business information services company with $31 million in revenue in 2001 with a sale to D&B in 2003 for $119 million. Spain was also the founder, chairman and CEO of HighBeam Research, which he started in 2002 and sold to Cengage Learning in December, 2008. He also co-founded and serves as executive chairman of Newser, a news filtering and summarization service with an audience of over three million readers each month. Spain serves as a board member of Televerde a rapidly growing, socially responsible telemarketing service and InfoArmy a Silicon Valley-based company information service that is using crowd sourcing to revolutionize data collection, quality and delivery. Until recently Spain served on the boards of SmartAnalyst, a research company that serves the pharma industry and GuideStar, the largest and most trusted database of information on the not-for-profit sector. Spain is a member of the Board of Governors of Opportunity International, the largest and best capitalized micro-lender in the world. Spain has worked in the technology industry since 1979 and has a bachelor’s degree from the University of Chicago and a law degree from Boston University. He lives in the Chicago area with his wife and three daughters.
Follow Patrick Spain:
About First Stop Health, Newser, Occasion: We provide care that people love with 24/7 access to licensed doctors via app, web or phone.
H. David Shockley
Founder and CEO of International Biophysics Corporation
H. David Shockley, Jr. co-founded Inova Labs in 2002 and has served as President since then. Prior to working at Inova, Shockley co-founded International Biophysics Corporation (IBC) in 1992 where he also serves as President. Shockley has oversight for both Inova Labs and IBC of sales, marketing, financial and general management functions. In addition, he has overseen the development of IBC’s international distribution channels and manufacturing partner relationships. Prior to forming IBC, Shockley held positions with CardioMetrics, a cardiovascular surgical technology firm, from 1987-1992. He began as a sales manager and was promoted to president within five years. Shockley also served as a sales manager for SciMed, now the core of Boston Scientific’s interventional cardiology business, from 1986-1989. Shockley was a founding member of the Austin, Texas, chapter of the Young Entrepreneurs’ Organization, now the Entrepreneurs’ Organization (EO). He holds a Bachelor of Arts degree in Biology from The University of Texas at Austin.
Follow H. David Shockley:
About International Biophysics Corporation, OrganiCare: International Biophysics Corporation is a marketing agency for medical devices and technologies that improve treatment therapies.
CEO & President of Texas Health Presbyterian Hospital Rockwall
Follow Cindy Paris:
About Texas Health Presbyterian Hospital Rockwall: Texas Health Presbyterian Hospital Rockwall is a hospital & health care firm offering acute care services.
President & CEO of Pryor Medical Devices
David Spencer is the Founder & CEO of Prytime Medical Devices & he Attended UT Austin in 1983.
Follow David Spencer:
About Pryor Medical Devices, Prytime Medical Devices, Texas Business Leadership Council, Texas Intrepid Ventures, The Bank of San Antonio, The University of Texas at San Antonio: Pryor Medical Devices The REBOA CompanyTM – was formed to provide minimally invasive solutions for noncompressible torso hemorrhage.
Chief Executive Officer of Seno Medical Instruments
Thomas Umbel is Chief Executive Officer of Seno Medical Instruments, Inc. Tom Umbel brings more than 30 years of medical device and diagnostics leadership experience to Seno Medical. He has lead several start-up companies, including one through a successful acquisition. He has also managed large organizations through significant growth leading both the strategic development and M&A efforts in his previous roles. Tom was most recently the VP of Business Development for Bioventus, a privately held ortho-biologics company in Durham, NC. Tom has led the Business Development efforts at both Bioventus and Hologic, the largest dedicated Women’s Health company in the U.S. Tom’s role in managing mergers and acquisitions helped to grow Hologic from a small single-product company with $100 million in revenue to a large diversified company with more than $2.5 billion in sales in his 15 years with the company. Prior to Hologic, Tom was the President of Direct Radiography Corp. (DRC). He led the development and commercialization of the digital x-ray detector technology, which he ultimately sold to Hologic in 1999. This company’s technology became the core to Hologic’s market leading digital mammography system and was the engine to Hologic’s significant growth. Prior to DRC, Tom worked at Sterling Diagnostic Imaging for 3 years and DuPont for 20 years. At those two companies, Tom held senior management positions in operations, engineering, sales and marketing. Tom has a BS in Chemical Engineering from Grove City College.
Follow Thomas Umbel:
About Seno Medical Instruments: Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Founder, President & Chief Executive Officer of Hormone Therapeutics
Hunter Howard has founded three successful HealthTech companies, following Fortune 100 experience, focusing on using technology to improve care access and quality while reducing costs. He built a 900 member medical billing company he sold to a PE firm and now has a national telemedicine platform focusing on home testing and access to specialist physicians anywhere for personal health optimization. Hormone Therapeutics and Therawell share the combined mission to Add Twenty Healthy Years to every Life! They provide patients a Scientific Map to personal Health Optimization using precision in-home testing (blood, hormone, genetic, biome, telomere) and a national telemedicine platform to decode and translate each unique biological make-up and develop ‘Personalized Therapeutics’ programs for an individualized scientific health map to optimal wellness. As life expectancy has increased 64% over the past 100 years (.001% of human evolution) their bodies are not keeping up. Hunter has a BA from SMU and MBAs from UNC and CEIBS in Shanghai China. His teams have won three INC 500 awards, three Dallas 100 awards, DBJ 40U40 and three national health startup competitions.
Follow Hunter Howard:
About Hormone Therapeutics: National telemedicine platform for health optimization using in-home testing and personalized therapeutics
CEO of Pro-Care Medical Center
Follow Brent Boecking:
About Pro-Care Medical Center: Pro-Care Medical Center is a comprehensive and individualized health care provider.
CEO of Xenex
Under Morris Miller’s leadership, Xenex has become a world leader in automated room disinfection. Through the use of Xenon technology and innovative hospital disinfection protocols, the company has helped hospitals achieve significant infection reduction results. As CEO, Morris is responsible for the company’s overall business strategy and oversight of day-to-day operations. Originally from San Antonio, TX, Morris is a graduate of the Dedman School of Law at Southern Methodist University, The University of Texas at Austin, and Phillips Exeter Academy. He is the founder of Sequel and Cutstone Ventures, which invests in/acts as an advisor to numerous start-ups such as Inventables, Adometry, and Golfballs.com. He started Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM, and he was also the co-founder and President/CEO of Rackspace (NYSE: RAX). Morris is a member of APIC, BioMed SA, and ACG Central Texas.
Follow Morris Miller:
About Capstone Ventures, Connell Curtis Group, Tectonic Ventures, Xenex: Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.
Chief Executive Officer of PMAM
Kumar is the Founder and CEO of PM AM; having over 30 years of experience in leading the operations of large multi-national corporations. Prior to his leadership role at PM AM, Mr. Kumar was the CEO of Birla Consultancy and Software Services (now PSI Data System) a CMM5 and ISO company with 15,000+ employees. In addition, Mr. Kumar led and oversaw IT operations for the Aditya Birla Group in Thailand and India which were responsible for some the organization’s highest valued initiatives. Appointed as the IT advisor to Chief Minister of an Indian state, he was responsible for developing the complete IT strategy for the state including all departments and infrastructure, as well as establishing the department responsible for its management and oversight on an on-going basis. This was an honorary position to which he volunteered his time to help the state.
Follow Pankaj Kumar:
About PMAM: PMAM Corporation is a global information technology company
CEO & President of Riceland HealthCare
TAHIR JAVED is the CEO and President at Riceland Healthcare.
Follow Tahir Javed:
About Riceland HealthCare: Riceland HealthCare is a network of physicians, hospital, hospice, home health and other services providing affordable patient care.
Co-Founder / CEO of DoctorLogic
Follow Stuart Lloyd:
About DoctorLogic: DoctorLogic offers an EHR-integrated marketing service that helps doctors grow their practice.
Founder & CEO of ThermiAesthetics
Paul was CEO of MedSurge Advances, which developed into one of the nation’s largest independent provider of aesthetic medicine products and services to physicians from 2003-2007 having launched 228 medical spas and provided assistance to more than 350 physicians who have entered the field of aesthetic medicine. MedSurge was named by Inc. magazine in 2007 as the 387th fastest growing private company in the United States. According to Inc., in 2002-2003 MedSurge also ranked among the 10 fastest-growing private companies in the greater Dallas/Fort Worth area. Paul serves on the Board of Directors for BioNorth Texas and is a mentor for Health Wildcatters. He has served on the Board of Directors of the American Society of Lasers, Medicine and Surgery (ASLMS) and was on the Board of Directors of Sona Med Spa from 2001-2003. Paul’s top areas of expertise include; Capitalization of all stage businesses, Business Development and Healthcare with a focus on Elective Procedures.
Follow Paul Herchman:
About Ideal Implant, ThermiAesthetics: ThermiAesthetics is a developer and manufacturer of thermistor-regulated energy systems for plastic surgery and dermatology applications.
President and Chief Executive Officer of Medical Innovation Labs
Drawn to entrepreneurship while attending graduate school in Biomedical Engineering, Michael entered medical school with a different perspective than most of his peers. Upon discovering some antiquated medical technologies, Michael began exploring ways to improve the standard of care. During his clinical years, his moonlighting included the design and development of various medical devices, and the successful completion of patient trials at MD Anderson Cancer Center in Houston. Upon graduation, Dr. Patton founded a company that developed a line of minimally invasive surgical instruments, which were recently acquired by a Fortune 500 company. Having navigated the arduous path of medical device development and commercialization, he is now committed to helping inventors turn their ideas into products that can improve health care. Michael received his MS in Biomedical Engineering from The University of Texas at Austin, and his MD from The University of Texas Medical Branch at Galveston.
Follow MICHAEL PATTON:
About Medical Innovation Labs: Medical Innovation Labs is a new hub for healthcare innovation in Central Texas.
Michael E. Steadman
Chief Executive Officer of URGO Medical North America
Follow Michael E. Steadman:
About URGO Medical North America: URGO Medical North America provides medical devices and products for hospitals, wound care centers, nursing homes, and home health agencies.
CEO of Airrosti Rehab Centers
Mr. Green brings a vast array of business experience to Airrosti. He spent 20 years with CUC International, an international marketing firm and one of the first companies to offer products online and through the Internet. CUC went from IPO to a $15 billion market cap company during Green’s tenure. Mr. Green held several positions at CUC including Senior Vice President of Sales and then Senior Vice President — Product Management where he managed the CUC Auto Service, CUC Warranty Services and CUC Dining Services from startup to over $200 million in revenue. Green then became President of CUC Publishing which merged with Entertainment Publications after its acquisition by CUC. Green then served in the Office of the President with responsibility for its 150+ offices throughout the US and select international locations. Green’s last three years at CUC were in the role of Executive Vice President — Mergers and Acquisitions where he was responsible for the negotiation and closing of numerous strategic acquisitions. Upon leaving CUC, Green purchased PC Wholesale, a custom technology builder and solution provider which has been included in the INC 500 list of fastest growing private companies and was also named one of the top 50 companies in San Antonio, Texas by the San Antonio Business Journal. Mr. Green was also a founding partner of Ventanex, Ltd. Ventanex provides custom phone payment services, integrated real time web payments, and electronic check conversion to mortgage servicers, banks, newspapers, credit companies and other firms seeking to move money efficiently. Mr. Green joined Airrosti as its CEO in March of 2006. Seeing that the current healthcare system is hungry for “results based” treatment options, Mr. Green is focused on further strengthening the unique culture at Airrosti that is committed to positively impacting the lives of our patients by attracting and supporting true Airrostifarians who have a genuine passion for helping others as part of their core DNA. Mr. Green became Airrosti’s Chairman of the Board in September 2018. “Our commitment to excellence gives Airrosti a unique opportunity to help patients, even those who have given up on finding relief for their pain and functional issues. Our patient outcome data proves we have an unparalleled track-record of resolving injuries quickly and completely. I have never been involved in anything so rewarding and it is an honor to support our treatment teams as they work daily to help Airrosti patients return to active and healthy lives.” Mr. Green has a BA in Marketing from the University of Washington in Seattle.
Follow Kelly Green:
About Airrosti Rehab Centers: Airrosti is an outcome-based healthcare group filling the value gap in musculoskeletal care.
CEO, Head of Product, and Founder of Rex Animal Health
Amado is a scientist turned entrepreneur. He is a chemist by training and is experienced in pharmaceuticals and big data/analytics. Prior to founding Rex Animal Health, he was advising startups and Fortune 500 companies in product development and intellectual property strategies.
Follow Amado Guloy:
About Rex Animal Health: Rex is take care animal health to the 21st century by making veterinary medicine and husbandry data driven.
President & CEO of Compression Works
Scott Dodson is President, CEO and a member of the board for AirXpanders. He has over twenty-two years of executive management and leadership experience in the medical device industry with Boston Scientific, Orthofix Orthopedics and BarrX Medical. Most recently, Scott Dodson was the President and CEO of Avantis Medical Systems where he led the company through their Series C financing and two successful bridge financings. He oversaw the securing of Medicare reimbursement, the completion and publication of the largest tandem designed, randomized trial in medical device history and the development of a next generation imaging system for global full market release. Scott Dodson has a Bachelor of Science in Management from Indiana University in Bloomington, Indiana and has completed the Executive Management Program of both Columbia University and Babson College.
Follow Scott Dodson:
About Bobber Interactive Corporation, Compression Works: Compression Works is the developer and manufacturer of the AAJT-S, the abdominal and aortic junctional tourniquet – stabilized.
Chief Scientific Officer & CEO of Vapogenix
Dr. Giles has held international leadership positions in large and small pharmaceutical companies, and her wide experience spans drug discovery and development from target validation, through clinical studies to final regulatory submission. She has a track-record of creating sustainable R&D portfolios and delivering new drugs into development and on to market. She has expertise in numerous therapeutic areas including respiratory, inflammation, pain and cardiovascular and is a respected pharmacologist with international recognition in the field of receptor theory and GPCRs. Dr. Giles joined Vapogenix in 2009 and has provided scientific and drug development leadership, which resulted in successful completion of the company’s first clinical study in 2014. Previously, from 2001 to 2008, she was Vice-President of Strategic Planning at Encysive, a small pharmaceutical company in Houston, Texas. There she managed the R&D portfolio and played a pivotal role in delivering the company’s key development project, Thelin, to regulatory submission and subsequent European commercial launch. Thelin is an endothelin A receptor antagonist for treatment of pulmonary arterial hypertension. Prior to Encysive, Dr. Giles was International Disease Strategy Director for Asthma at GlaxoSmithKline R&D and prior to this was Head of the Receptor Pharmacology department at GlaxoWellcome R&D, UK (1995-2000). From 1983-1995, at Wellcome R&D, UK, she held various research, project leader and management positions, with particular focus on G-protein-coupled receptors and integrins and their role in cardiovascular disease. She has an extensive scientific publication record and currently serves as adjunct Associate Professor in the Department of Pharmacology at the University of Houston. She is a member of the British Pharmacological Society and has served on their governing council and is an Editor for the British Journal of Pharmacology.
Follow Heather Giles:
About Vapogenix: Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain.
CEO of SubjectWell
Follow Ivor Clarke:
About Brightfire, SubjectWell: SubjectWell is the risk-free clinical trials marketplace for patient recruitment
Founder & CEO of Hua Medicine
Dr. Li Chen leads Hua Medicine, a drug discovery company whose mission is to bring clinically differentiated medicines to patients in China and worldwide. Before Dr. Chen founded Hua Medicine, he was the Chief Scientific Officer and Head of Research at Roche R&D Center (China) Ltd. and a member of Roche’s Pharma Research Leadership Team. As a founding Director in this position, Li was responsible for development and implementation of China’s drug discovery strategy, creation of the China discovery portfolio, and management of China operations including Biology, Chemistry, Pharmacology, Discovery Technology, Drug Supply and Drug Safety. He developed a “Collaborative Innovation” model through integration of over 100 scientist-based China partnerships with academic institutes, biotech, contract research organizations and clinical development organizations. During his 18 year pharma career, Li also had several leadership positions at Roche Nutley in New Jersey, including head of combinatorial/high throughput chemistry. He is a co-inventor of two Roche drugs that reached Phase II clinical trials in Asthma and in MED. He also served as a member at Roche’s Patent Coordination Committee at Nutley. Li was the President of the Sino-American Pharmaceutical Professionals Association (SAPA) in 2001, and is now a member of the SAPA Board of Directors. He has received numerous honors including the Roche Pharma Olympia Award 2005, Roche D2K Award, and SAPA President’s Award. Most recently, he received IBC China Pharma’s R&D Award, which recognizes outstanding individuals whose contributions changed the landscape, reputation, and ecosystem for drug R&D in China. He has also received the “Shanghai Leading Talent” Award from the Shanghai government. Li received his Ph.D in Chemistry from Iowa State University. He was formerly a lecturer in Organic Chemistry at East China Normal University, and is currently an adjunct professor of Chemical Biology at Tongji University. He has over 70 publications in numerous peer-reviewed scientific journals and in patent literature.
Follow Li Chen:
About Hua Medicine, Tongji University: Hua Medicine is a clinical-stage, innovative drug development company in China.
Founder and CEO of Practice EHR
Follow Khurshid Mughal:
About Practice EHR: Practice EHR is a cloud-based and specialty-specific EHR and practice management (PM) solution.
Kelly S. Drewry
Founder & CEO of Renova Health
Follow Kelly S. Drewry:
About Renova Health: Renova® provides access to specialized care for neuropathic pain related to back, neck, hand and foot conditions.
President & CEO of Vascular Perfusion Solutions
Tom DeBrooke is the President and Chief Executive Officer at Vascular Perfusion Solutions.
Follow Tom DeBrooke:
About Vascular Perfusion Solutions: Vascular Perfusion Solutions develops medical devices designed to preserve and resuscitate vascularized organs.
President & CEO of CTL Medical
Daniel Chon is the Founder and CEO at CTL AMEDICA.
Follow Daniel Chon:
About AccelSPINE, CTL Amedica, CTL Medical: CTL Medical Corporation assembled a world class executive team, bringing together some of the industry’s most exceptional talent.
President and Chief Executive Officer of Leto Solutions
Becky Ariana, who served as the team’s mentor throughout the UTSA CITE competition, is the Company’s President and CEO. Ms. Ariana brings more than 30 years of experience in strategic planning, marketing and sales management, and executive leadership in the medical industry, working with organizations ranging in size from small start-ups to industry giants. Most recently, she served as a Principal with ProSavant International, a successful and highly recognized San Antonio-based strategic and operational consulting firm in the medical industry. Prior to joining ProSavant, she was VP at Vidacare Corporation, with responsibility for creating, building, and leading the oncology business unit. In addition to being President of Medigy Consulting for 10 years, Ms. Ariana has had the opportunity to launch exciting and innovative new products for Millennium Pharmaceuticals (the Takeda Oncology Company), Berlex Oncology (Bayer Healthcare Pharmaceuticals), Diatek Corporation, and IVAC Corporation (now Carefusion). Ms. Ariana received her B.S. degree in Zoology and Psychology from Iowa State University, and completed additional coursework at the University of Chicago.
Follow Becky Ariana:
About Leto Solutions: Leto Solutions Inc.is a small start-up company that developed the Aquilonix™ Prosthesis Cooling System.
Chief Executive Officer of Siva Therapeutics
Len Pagliaro, PhD, has 18 years of experience with successful commercialization of biotechnology products, services, and licensing, following an academic career. He has managed R&D and business development teams, and brought product lines from concept through commercialization to acquisition. A small molecule oncology project he led was successfully partnered with TopoTarget, and is now in the clinic. Len managed the P&L for a business unit of Thermo Fisher Scientific selling tools for drug discovery before co-founding Siva. He is responsible for overall corporate strategy and financing.
Follow Len Pagliaro:
About Siva Therapeutics: Siva Therapeutics is a biotechnology company developing nanotechnology approaches for treating cancer.
Vinit K. Asar
President and CEO of Hanger
Mr. Vinit K. Asar is President, Chief Executive Officer, Director of Hanger Inc. Mr. Asar came to Hanger from the Medical Device & Diagnostic sector at Johnson & Johnson, having worked at the Ethicon, Ethicon-Endo-Surgery, Cordis and Biosense Webster franchises. During his 18 year career at Johnson & Johnson, Mr. Asar held various roles of increasing responsibility in Finance, Product Development, Manufacturing, and Marketing and Sales in the US and in Europe. Prior to joining Hanger, Mr. Asar was the Worldwide Vice-President at Biosense Webster, the Electrophysiology division of Johnson & Johnson, responsible for the Worldwide Sales, Marketing and Services organizations. Mr. Asar has a B.S.B.A from Aquinas College and an M.B.A. from Lehigh University.
Follow Vinit K. Asar:
About Hanger: Hanger, Inc. is the world’s premier provider of orthotic and prosthetic (O&P) services and products,
J. Brian Windsor
Chief Executive Officer of Lung Therapeutics
Windsor has spent the last 18 years in the formation and management of life science-based technology ventures and has led technology development and licensing to major pharmaceutical firms as well as public and private companies. Dr. Windsor brings recent leadership experience in pharmaceutical drug development and most recently served as President of Enavail, LLC, a specialty pharmaceutical manufacturing company developing unique formulations for superior drug performance. While at Enavail, Dr. Windsor oversaw all aspects of pharmaceutical drug development, including drug selection, regulatory strategy, preclinical and clinical strategy, GMP manufacturing, and strategic partnering for pharma products. Prior to his role with Enavail, Dr. Windsor directed portfolio company management for Emergent Technologies Inc. (ETI), an early stage technology venture creation and management company. During his tenure at ETI, Dr. Windsor has served as Managing Director or President for ten of ETI’s portfolio companies and has been involved in the conception, technology licensing, corporate and technical strategic planning, launch, and business development of all of these ventures. Applications areas of these companies span diverse segments within life and material sciences and include pharmaceutical development and manufacturing, drug delivery, and biotechnology. Prior to joining ETI, he was Founder and Vice President of R&D for Texagen, Inc., a startup focused on genetic and chemical methods for overcoming mechanisms of drug resistance important to medicine and agriculture. At Texagen he directed outsourced research efforts at university labs and third party contract research companies, and he interfaced with corporate partners interested in feasibility studies and in-licensing discussions. He holds a PhD in Molecular Biology from The University of Texas at Austin, is an invited speaker for both scientific and technology transfer events, and is an inventor on multiple patents and patent applications.
Follow J. Brian Windsor:
About Lung Therapeutics: Lung Therapeutics provides innovative treatments for underserved, life-threatening lung conditions.
Founder, CEO and CTO of BiVACOR
Daniel Timms, PhD, is the founder of BiVACOR, Inc. A graduate of the Queensland University of Technology, Dr. Timms completed his postdoctoral training at The Prince Charles Hospital’s cardiac transplant center in Brisbane, Australia, and at the Helmholtz Institute in Aachen, Germany, one of Europe’s leading cardiovascular device research centers. He has more than 15 years of experience in mechanical circulatory support development.
Follow Daniel Timms:
About BiVACOR: BiVACOR designs and manufactures centrifugal heart pumps.
Chief Executive Officer of Eyevensys
Follow Patricia Zilliox:
About Eyevensys: Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.
Founder, CEO of Infinite Recovery Holdings
Michael Dadashi has been living in active recovery since 2009. He used the transformative lessons that he learned in recovery to rebel against what society tells us about addicts and empower those seeking a transformed life. By hiring other people in long-term recovery, Michael built a multi-million dollar e-waste recycling business that became one of the fastest growing private companies in the United States. In 2013, Michael took his mission to help addicts rebuild their lives one step further by opening Infinite Recovery.
Follow Michael Dadashi:
About Heart Water, Infinite Recovery Holdings, MHD Enterprises: Infinite Recovery is an addiction rehabilitation center based Austin, Texas.
Co-Founder & CEO of Genova Health
Prior to co-founding Genova, Alex co-founded Family Tree In-Home Senior Care and grew it to become the leading home care company in Houston, Texas. Alex serves on various industry boards including the Alzheimer’s Association (Houston & Southeast Texas Chapter), Houston Gerontological Society (Vice President) and HYPAA (Houston Young Professionals Against Alzheimer’s Disease). Additionally, he is a board member of the Texas Wranglers Alumni Association, the prior Chairman of the Private Duty Committee of the Texas Association for Home Care and Hospice, and an associate member of the UTHealth Consortium on Aging. Alex is active in outreach and volunteer efforts in the community, including his work with the Ms. Wheelchair Texas Foundation.
Follow Alex Bonetti:
About Genova Health: Genova Health manages a portfolio of integrated solutions that leverage applied research and clinical care methodologies.
Chairman & Chief Executive Officer of Aminex Therapeutics
Jim has been with Aminex since 2012. He was one of six top executives with NASA’s Apollo lunar landing program management, and he has spent almost 40 years in several corporate leadership positions in high-tech electronics systems, heavy infrastructure maintenance equipment manufacturing, and biotech drug development. Jim is retired chairman of Alamo Group, Inc. (NYSE) Prior to that, as chairman, CEO, and president of Tracor Inc., he led the turnaround and six times growth of Tracor in the defense electronics industry with 10,000 employees. Tracor was a Fortune 100 Fastest Growing Company. Jim graduated with a bachelor’s degree in mechanical engineering from the University of Washington and has received numerous honorary awards.
Follow Jim Skaggs:
About Aminex Therapeutics: Aminex Therapeutics develops small molecule based cancer treatment solutions.
Chief Executive Officer of Cure Staffing
Follow Brandon Armstrong:
About Cure Staffing: Cure Staffing is specialize in providing the healthcare staffing community with per diem, contract and direct hire staffing solutions.
Chief Executive Officer of Decisio Health
Follow Bryan Haardt:
About Decisio Health, Rice Business – Jones Graduate School of Business: Decisio Health is a Helping care providers reach accurate decisions quickly and easily.
Chief Executive Officer of Health & Safety Institute
Frank Powers is the Chief Technology Officer for HSI and is responsible for the development of the information technology infrastructure that manages all the HSI brands. He brings 15 years’ experience developing health and safety training businesses to this role. Prior to assuming his role of CTO, Frank was the Chief Operating Officer at American Safety and Health Institute (ASHI), the CPR and first aid division of HSI. Before joining ASHI, he was the Director of AED Training and Implementation for Cardiac Science, where he drove the expansion of a national training network of over 200 educators and the automation of training class delivery to 8,000 classes a year. Frank has served in senior management roles with Complient Corporation, Quaker State and Blue Coral/Slick 50.
Follow Chad Birckelbaw:
About Health & Safety Institute: Health & Safety Institute is a provider of EH&S training solutions to customers in the United States and Canada.
CEO and Principal of Phoenix Ortho
Paul got his start in healthcare in 1971 as a scrub nurse and surgical assistant at Parkland Memorial Hospital in Dallas. He later received a Bachelor of Science from the University of Texas-Arlington and an MBA in Healthcare Administration from the University of Dallas. His advanced education and background, together with the emergence of HIT technology, led Paul on a long professional journey. He started working in sales for practice management billing software and electronic health records (EHR) in 1988; in 2006, he introduced Phoenix Ortho, the first orthopaedic-specific EHR platform. Phoenix Ortho is an innovative solution rooted in improving efficiency and effectiveness within the orthopaedic field. It has made a difference for more than 1,000 providers in 44 states.
Follow Paul McCune:
About Konica Minolta Healthcare Americas, Merry X-Ray, Phoenix Ortho: Phoenix Ortho provides orthopaedic-exclusive suite of products integrating EHR, PACS and Practice Management software.
Founder & CEO of Oculus Health
Follow Sridhar Yerramreddy:
About Oculus Health: Oculus Health is a digital remote care management company.
CEO of SignalPath
Follow Bradford Hirsch:
About SignalPath: SignalPath is designing the next generation of software for the clinical research site and sponsor.
Founder & CEO of knowRX Inc.
David, a Navy veteran, is a seasoned technologist with more than 22 years of experience. He has participated in two IPOs and delivered more than 10 applications to market. Over the last decade, Franklin has focused on cloud computing and machine learning for health care applications. He has studied at Moody Bible, Penn State, and MIT
Follow David Franklin:
About knowRX Inc., Pledge 1%: knowRX™ a cloud-based digital healthcare platform that addresses various encounters important to proper therapeutic care.
Founder and CEO of Paragon Innovations, Inc.
Follow Mike Wilkinson:
About Lavon Water Sports, Paragon Innovations, Inc.: Engineering Product Development Company
CEO of MDRing
Follow Matt Olds:
About : Modern, mobile medical education for multidisciplinary healthcare teams.
CEO of MedicalRecruiting.com
Follow Blake Moser:
About MedicalRecruiting.com: MedicalRecruiting.com recruitment services for healthcare professionals such as physicians, nurse practitioners, physician assistants.
Co-Founder & CEO of IntuiTap Medical, Inc
Jessica was trained in Mechanical Engineering at Purdue University and has a strong foundation in product development and design. She has product management and design experience in a wide range of applications, including custom prosthetics, medical devices, and consumer goods.
Follow Jessica Traver:
About IntuiTap Medical, Inc: IntuiTap Medical is a medical device company that is eliminating the guesswork from spinal taps and epidurals.
CEO of National Surgery Network
As the founder of National Surgery Network, Ken Erickson brings almost a decade of healthcare industry experience to deliver the first next-generation provider network. Ken Erickson began his career with the early development and growth of Costco Wholesale where he helped execute the vision of its founders to redefine retailing. During the late 1990s, he built the sales and marketing organizations at Value America, the first national scale Internet retailer. This experience positioned him to lead the emergence of a new market for healthcare services. As founder of the first International PPO, Global Choice Healthcare, and of the first domestic medical-travel network, Healthplace America, Erickson was among the first to apply basic business, economic, and marketing principles to healthcare. By doing so, he established the first medical network built on global case rates, allowing health plans to understand the actual costs of major medical procedures. More importantly, ken Erickson recognized the triangular relationship of the plan as customer, the plan member as consumer, and the provider as vendor to deliver a market-based solution that benefits all three participants. He is also a frequent speaker on the subject of the importance of transparency and competition in healthcare.
Follow Ken Erickson:
About National Surgery Network: National Surgery Network provides a new way for self-funded employer health plans to purchase planned medical procedures for their members.
President and CEO of Texas Crop Science
Simon Hiebert founded Texas Crop Science in 2012, while enrolled at The University of Texas at Austin. Since his graduation in 2013, Mr. Hiebert has managed the Company’s operations and continued growth. In addition to his responsibilities at Texas Crop Science, Mr. Hiebert is actively involved with the Austin, TX chapter of the Juvenile Diabetes Research Foundation. Mr. Hiebert holds a bachelor’s degree from the University of Texas at Austin.
Follow Simon Hiebert:
About Texas Crop Science: Texas Crop Science is a agricultural technology company.
President and Chief Executive Officer of Westlake Chemical Corporation
Follow Albert Chao:
About Westlake Chemical Corporation: Westlake Chemical Corporation is a manufacturer and supplier of petrochemicals, polymers and building products.
CEO of Elligo Health Research
John Potthoff serves as the Chief Executive Officer at Elligo Health Research.
Follow John Potthoff:
About Elligo Health Research: Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Tracey B. Kirsch
Chief Executive Officer of Electrum Customer Care Number
Ms. Kirsch is the president of Electromedical Products International, Inc. (EPI) where she manages all financial matters, human resources, regulatory affairs and oversees daily operations. She maintains close working relationships with the company’s personnel and its worldwide network of independent distributors. She successfully orchestrated the company’s move from California to Texas in 1994 and was instrumental in gaining regulatory approval for the company’s products in many countries including Europe (the CE Mark), Australia, Canada, China, and various countries in South America, Africa and the Middle East. In 2005 Tracey negotiated a Federal Supply Schedule contract with the United States government for use of Alpha-Stim within the Department of Defense and Veteran’s Affairs Medical Centers. Within a few years, the U.S. government, mainly the Army and Navy, as well as some 90 Veteran hospitals, became the biggest Alpha-Stim customer. That market segment continues to grow, and she and her company take great pride in helping U.S. Service Members and veterans treat pain and post traumatic stress. Since earning her BA in psychology from the University of New Orleans, she has attended numerous continuing education programs for non-profit corporations, FDA regulations, pain, psychiatry, stress, and related medical conferences. She has taught programs on Agency Policy and Procedures, Clients’ Rights, Federal Regulations Survey and Follow-up, among others.
Follow Tracey B. Kirsch:
About Electrum Customer Care Number: Electromedical Products International is a medical device company engaged in the manufacturing and marketing of Alpha-Stim.
CEO, Co-founder of Practice Insight
Houston Johnson has over 32 years of experience in marketing, implementing, and supporting practice management systems and EDI services for physician practices, billing services and management service organizations (MSOs). Before he founded Practice Insight, Houston was Director of Marketing and an original partner in MedsAmerica, Inc. He developed the marketing program for that company from its inception until it was acquired by Medical Manager Corp. in 2000. He was also an original founder and partner in AmeriClaims, Ltd. and E-Bills, Ltd. from inception through their acquisitions in 2000. Houston has been involved in marketing, sales, and system implementation for over 600 clinics of various sizes and specialties.
Follow Houston Johnson:
About Practice Insight: Practice Insight is a provider of revenue cycle management and electronic data interchange solutions for healthcare providers.
CEO / SYSTEM ARCHITECT of Practice Insight
Mike Reeves has over 34 years’ experience in the physician practice management software market. In 1976, while pursuing his Master’s degree in Hospital and Healthcare Administration, he developed a strong interest in computer technology and software. Mike pioneered the development of some of the first mini- and microprocessor medical office computer systems used in the United States. With such deep experience, he has been the driving force behind the development of the Practice Insight® EDI solutions. He is the co-architect of the Internet-based graphical user interface technology in all Practice Insight applications. Before founding Practice Insight, Mike was the President, CEO, and original founder of MedsAmerica, Inc., which developed, sold, and supported practice management software to over 3,000 physicians until its acquisition by Medical Manager Corp. (now WebMD). He was also the primary developer and original partner in AmeriClaims, Ltd, a claims clearinghouse, and E-bills Ltd., an electronic statement processing company. Mike led these companies from their startup until they were acquired by other companies in 2000.
Follow Michael Reeves:
About Practice Insight: Practice Insight is a provider of revenue cycle management and electronic data interchange solutions for healthcare providers.
President, COO, CEO and Co-founder of Practice Insight
Denise is the chief architect of the Practice Insight claims management system. In addition to her role as President, she is also the Chief Operating Officer overseeing all aspects of Practice Insight operations. Denise has 20 years of experience in the healthcare software industry. Before helping to found Practice Insight, she was the Director of Implementations for MedsAmerica, Inc. While there, Denise was key to automating software conversions, implementations, and streamlining new installs. Denise also trained and provided consulting services to all of the MedsAmerica providers. She was instrumental in driving the development and features of the CMEDS suite of products.
Follow Denise Perry:
About Practice Insight: Practice Insight is a provider of revenue cycle management and electronic data interchange solutions for healthcare providers.
Co-Founder, CEO & Chief Scientist of Resonant Sensors Inc.
Debra Weidanz is the Co-Founder & Chief Executive Officer at Abexxa Biologics.
Follow Debra Weidanz:
About Abexxa Biologics, Resonant Sensors Inc.: The mission of Resonant Sensors Incorporated (RSI) is to become a global leader for rapid biosensor screening systems for the.
CEO of DISA Global Solutions
John Peterson is the CEO of DISA Global Solutions, a provider of workplace safety and compliance services.
Follow John Peterson:
About DISA Global Solutions: DISA has been providing innovative workplace safety and compliance services for over 25 years.
Founder & CEO of HER Technologies
Sarah Stack is the founder and chief executive officer at HER Technologies.
Follow Sarah Stack:
About HER Technologies: HER Technologies is a biotechnology company developing a suite of technologies that restores skin to a healthier more youthful state.
President & CEO of ENTvantageDX
Follow Joe Skraba:
About ENTvantageDX: ENTvantage Diagnostics is a medical diagnostics company that develops and markets in-office diagnostic tests.
President & CEO of Bone Solutions
Follow Drew Diaz:
About Bone Solutions: Bone Solutions is a medical device company that provides new technologies to orthopedic surgeons to improve clinical results.
CEO of AMCHART
Follow Aman Quadri:
About AMCHART: AMCHART is a patient driven EHR on a hybrid public/private blockchain with AI for analytics and an incentive drive model.
Elyse Stoltz Dickerson
CEO & Founder of Eosera, Inc.
Follow Elyse Stoltz Dickerson:
About Eosera, Inc.: Eosera is a new biotechnology company aiming to address underserved medical needs.
Co-Founder, CEO, President and Director, of ASR Systems
Mike Girouard is the CEO, President, Director, and Co-Founder of ASR Systems. He has 30+ years leading teams in medical device development and commercialization. He was the CEO, President, Director, Co-Founder, Brain Sentinel, Inc., Past Managing Director, GXC Global LLC, Past Director, Global Portfolio Management, KCI, and an inventor of over 20 U.S.-issued patents.
Follow Mike Girouard:
About ASR Systems: ASR Systems designs, develops, and commercializes surgical retractor systems.
Co-founder, President & CEO of Proxima Clinical Research Inc.
Follow Kevin Coker:
About Forbes Business Council, Proxima Clinical Research Inc.: Proxima is a Contract Research Organization, purpose-built to meet the needs of emerging medical device and biotech companies.
CEO of Ion Biotechnology (USA), Inc.
Dennis Stone has 40 years of management, technology, commercialization, and international experience. With NASA for 30 years, he led support to the commercial space industry and helped manage a nearly $1B NASA investment portfolio including in Elon Musk’s SpaceX. A proponent of microgravity for bio/pharma research, Mr. Stone helped build demand for space in the life sciences. His other NASA experience includes program management, system engineering, and international relations. He is founder and President of World Space Week Association which stimulates STEM education via an annual UN-declared event in 86 nations. He has dual Bachelor of Science degrees in Physics and Electrical Engineering from the University of Hawaii.
Follow Dennis Stone:
About Ion Biotechnology (USA), Inc., NASA: Ion Biotechnology is developing drugs based on ionic metals which show promise against a range of cancers and infectious disease.
CEO and Founder of M&S Biotics
Follow Joshua Mecca:
About M&S Biotics: M&S Biotics is a healthcare IoT company that automates surgical processes in the operating room through AI and RFID technology.
Founder, President & CEO of AptamiR Therapeutics
Dr. Thibonnier is Founder, President, CEO, and member of the Board of Directors at AptamiR. He led a successful career in academic medicine, followed by ten years of leadership in drug development at Bayer, BMS and GSK, overseeing cardiovascular and metabolic drug development from candidate selection to regulatory approval. Dr. Thibonnier earned an M.D. at the Université Pierre et Marie Curie and a M.Sc. at the University of California, San Francisco. He currently holds an appointment as Clinical Professor of Medicine at Stanford University.
Follow Marc Thibonnier:
About AptamiR Therapeutics: AptamiR Therapeutics is a biotechnology company that focuses on developing a revolutionary treatment for human obesity.
CEO of Emerge Clinical Solutions
Scott Finfer proudly serves as the CEO of emerge Medical Data Intelligence. An alumnus of Texas A&M University and the Harvard Business School’s Advanced Management Program, Mr. Finfer’s career officially began with American Express as a financial advisor. A few years later, he began his entrepreneurial journey. His success in private real-estate development led him to join several top public home builders, including KB Home, as Vice President of Land and Acquisition. Over the course of his career, Mr. Finfer has overseen the acquisition and development of more than 12,000 residential lots with a sell-through exceeding $1 billion.
Follow Scott Finfer:
About Emerge Clinical Solutions: Emerge Clinical Solutions empowers healthcare professionals with medical data intelligence.
Co-Founder & CEO of Articulate Labs
Josh has been a driving force of Articulate Labs since he first uncovered the unexpected market size that can benefit from a device conceived for a single user. He is responsible for all non-technical aspects of the company, with focus on initial market definition and development, fundraising, grants, and communications. Prior to Articulate Labs, his diverse background includes serving a variety of policy analysis roles in both the Michigan House of Representatives and the Texas Senate, as well as writing and administering over $3 million in grants for College Forward, an organization helping disadvantaged high school students apply, enroll into, and succeed through higher education. He graduated from Michigan State University in 2006.
Follow Josh Rabinowitz:
About Articulate Labs: Articulate Labs develops wearable devices that augment movement with electrical stimulation to turn everyday activity into on-the-go rehab.
CEO of Instapath
Mei Wang is a co-founder and the CEO of Instapath Inc.
Follow Mei Wang:
About Instapath, Instapath: Instapath provides digital imaging tools for rapid on-site pathology evaluation to repeat biopsy procedures and increase hospital revenue.
President and CEO of RedAway Medical Waste
Follow Justin Smith:
About RedAway Medical Waste: RedAway is a Medical Waste Solutions Company that facilitates safe and secure transportation and processing of non-hazardous medical waste.
CEO & President of Bluegrass Vascular Technologies
Gabriele Niederauer is the CEO & President at Bluegrass Vascular Technologies, Inc.
Follow Gabriele Niederauer:
About Bluegrass Vascular Technologies: Bluegrass Vascular Technologies is in the business of innovating lifesaving devices and methods.
Chief Executive Officer of VRL Laboratories
Follow Ron Berger:
About VRL Laboratories: VRL Laboratories, one of the laboratories in pre-transplant testing for the eligibility determination for Donors of Human Cells.
Founder, CEO of Sensogram Technologies
Founder of Sensogram Technologies.
Follow Vahram Mouradian:
About Sensogram Technologies: Sensogram Technologies is a research and development company.
President & CEO of Millar
Tim Daugherty has served as President & Chief Executive Officer of Millar since July 2016. He joined Millar initially in 2003 as a Technical Sales & Support Engineer, where he developed an immediate appreciation for the typical Millar Customer’s high level of innovation, dedication to their craft and ultimate commitment to improving medical outcomes. Working initially with the cardiovascular product lines, he served in increasingly broader roles including Product Manager, Director of Sales & Marketing and President before his appointment as President/CEO in 2016. Tim believes that Millar makes a difference in the lives of patients, clinicians, and researchers every day and that it is the company’s purpose to push the limits of technology to enable new scientific discoveries and expand the boundaries of medical understanding in the name of continuously improving the health of mankind. His commitment to this core purpose guides his approach to developing Millar’s long term strategy. Since assuming the role of President/CEO, Tim has implemented a strategy to expand Millar’s presence in key clinical markets, where the Company’s novel technology platforms can drive improvements in patient outcomes and reduce long-term healthcare costs. This strategy includes bringing new Millar products directly to customers around the world, as well as facilitating the integration of Millar’s technologies into other devices in order to accelerate the impact of Millar’s technology on a wider scale. Tim grew in up Texas, Wyoming, and Kentucky, and earned a Bachelor of Science with Honors in Biomedical Engineering from Texas A&M University.
Follow Tim Daugherty:
About Millar: Millar is a medical devices company providing physiological monitoring solutions.
Founder & CEO of TeVido BioDevices
Laura Bosworth is CEO and co-founder of TeVido BioDevices. Ms. Bosworth is a dynamic former Fortune 50 executive with over 25 years of cross-functional industry experience. With over 18 years in product, process and service development at both the engineering and marketing level, she has experience launching new business start-ups within a larger corporation. She has led numerous successful strategy efforts. Ms. Bosworth has served with several applied entrepreneurship programs, mentoring aspiring entrepreneurs to develop their own high-growth (more than a $1 Million) companies. Ms. Bosworth has served on UTEP’s College of Engineering Advisory Board and in 2010, she led a task force that recommended a strategy to create a culture of innovation and entrepreneurship and is now involved in its implementation. With a B.S. in Metallurgical Engineering from the University of Texas at El Paso she started her career in manufacturing process development for IBM Austin. She quickly moved into management where she led custom software development projects and launched a Technical Marketing Center earning a General Manager’s Award for her contributions to sales. At Dell, she led organizations in building strategic business partnerships, software product marketing and created multiple technical sales support functions: enabling over $500M in sales. She launched a professional services business unit and has expertise in customer support services. Using her cross-functional and international experience, she developed corporate wide strategies that reduced operating costs by ~$120M and improved customer satisfaction by 40-50%
Follow Laura Bosworth:
About TeVido BioDevices: TeVido makes life-changing skin cell transplants available to those who need them.
CEO of Galileo CDS
Follow Abhijeet Pradhan:
About Galileo CDS: Galileo builds clinical decision support tools for radiology using Deep Learning and Bayesian Learning.
Founder , President & CEO of PotentiaMetrics
Robert is an experienced technology developer, entrepreneur, and executive with over 20-years of industrial experience in developing analytic models for healthcare payers, providers, life sciences, professional sports, financial services, private equity, and manufacturing. Robert developed the firm’s PotentiaMED analytics products including comparative effectiveness analysis and predictive analytics for clinical and economic outcomes. He has also held executive leadership across various privately held companies and startups. Robert holds an MBA from Washington University, Olin School of Business, and a BS in Business Administration from Regis University. He is a member of the William Greenleaf Eliot Society and the YPO (Young Presidents Organization).
Follow Robert Palmer:
About PotentiaMetrics: PotentiaMetrics provides personalized and predictive AI platforms supported by proprietary real-world outcomes registries.
Michael C. Zucker
CEO & Co-Founder of Fetch MD
Michael C. Zucker is a Co-Founder and Chief Executive Officer at FetchMD.
Follow Michael C. Zucker:
About Fetch MD: Fetch MD provides a web-based patient referral directory for clinicians and healthcare professionals.
Chief Executive Officer and Director of Phoenix Biotechnology
Crandell Addington is a cum laude graduate from Southwestern University, Georgetown, Texas, majoring in economics and accounting. Addington received post-graduate education in various sciences at Trinity University, San Antonio, Texas. Addington has, over the course of 40 years, founded and/or operated successful enterprises ranging from chemical manufacturing to oil and gas exploration, development, and production. Addington is also President and Chairman of the Board of Anviram, Inc. As a result of his prior and current corporate leadership positions, Addington has been responsible, among other duties, for interacting with biomedical researchers and clinicians both in the United States and Latin America.
Follow Crandell Addington:
About Phoenix Biotechnology: Phoenix Biotechnology engages in the research and development of therapeutic agents and treatment regimens for cancer.
H. Kirby Atwood
President & CEO of Remicalm
Follow H. Kirby Atwood:
About Gulf Capital Partners, Remicalm: Remicalm, LLC, a medical diagnostic and imaging device company, engages in the design, manufacture, and marketing of cancer diagnostic,
David A. Burns
CEO of Remicalm
Follow David A. Burns:
About Remicalm: Remicalm, LLC, a medical diagnostic and imaging device company, engages in the design, manufacture, and marketing of cancer diagnostic,
Co-Founder & CEO of BioLum Sciences
Follow Edward Allegra:
About BioLum Sciences: Innovating Chronic Disease Management
CEO & Lead Blockchain of Blüpass
Follow Shawn Stephens:
About Blüpass: Blüpass is an ERC-20 utility token that enables multiple users to access their platform designed to better connect providers, carriers.
Kim Bond Evan
Co-Founder and CEO of Seremedi
Kim Bond Evans has more than 15 years as a senior executive for early stage and large companies. Kim is co-founder and CEO of Seremedi, Inc. a digital health company. Seremedi’s CareScriptions® mobile integrated care management and outcomes reporting application enables care teams to connect to patients during critical points of care at any virtual setting achieving the best outcomes. Previously, Kim served as the President of Blue Lance and the CEO of Secure Vantage Technology, Inc. where she was responsible for leading product directions and business strategies. Prior experience includes business development and M&A where she was responsible for identifying, investing, acquiring and integrating strategic assets for Microsoft and BMC Software. Kim completed the Wharton executive management program as a member of the Microsoft leadership team. Kim served as entrepreneur-in-residence for the Houston Technology Center and a member of the founding teams for the HATCHpitch competition and Impact Pediatric Health for innovative start-ups at SXSW. Kim serves as a judge at the distinguished Rice Business Plan competition; a coach for fast track early stage companies at SXSW Interactive and AARP. Kim is committed to the wellbeing of her family and communities. She serves on several boards and organizations. Kim holds a Bachelor’s degree from Wayne State University.
Follow Kim Bond Evan:
About Seremedi: A personalized guided care SaaS offering that providers prescribe to patients to optimize outpatient care flows
Founder & CEO of qapsula
Follow Dmitry Maznitsa:
About qapsula: qapsula offers a telemedicine service for online communication between patients and doctors.
CEO, Founder & CMO of ODIN Biotech Partners
Karl Csaky is the CEO, Founder, and Chief Medical Officer of ODIN Biotech Partners.
Follow Karl Csaky:
About ODIN Biotech Partners: ODIN Biotech Partners is a development-stage biotechnology company focused on developing novel peptide therapeutics.
CEO and CTO of TomoWave Laboratories
Dr. Alexander A. Oraevsky has over 25 years of experience managing R&D laboratories in academia and small businesses. Alexander obtained a doctorate in laser spectroscopy and laser biophysics from the USSR Academy of Sciences. In 1992, as Whitaker Fellow, he joined the faculty at Rice University. Prior to foundation of TomoWave Laboratories in 2010, he served as Vice-President of Research and Development for Fairway Medical Technologies, was the Director of the Optoacoustic imaging and Spectroscopy Laboratory at the University of Texas Medical Branch in Galveston. Dr. Oraevsky is the recipient of multiple research awards advancing biomedical applications of the optoacoustic imaging sensing and monitoring, including Berthold Leibinger Innovations Prize 2014. Alexander is the primary inventor of 21 patents, has published seven book chapters and over 200 highly cited scientific papers, and he is referred to as the Father of biomedical optoacoustic imaging.
Follow Alexander Oraevsky:
About TomoWave Laboratories: TomoWave commercializes and produces innovative imaging modalities with applications in clinical medicine and preclinical research.
D. Craig Noonan
Chief Executive Officer of Wellspring Benefits Group
Managing Partner responsible for finance, operations and marketing strategy. Accomplishments include over 30 years in developing companies into profitable organizations. Industry segments include: media, technology, training, consulting and intellectual capital development.
Follow D. Craig Noonan:
About Wellspring Benefits Group: Wellspring Benefits Group provides the best of technological innovations combined with personalized healthcare services that moves.